|
Volumn 323, Issue 5910, 2009, Pages 30-31
|
A viral link to glioblastoma?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOMEGALOVIRUS VACCINE;
PLACEBO;
VALGANCICLOVIR;
ANTIVIRUS AGENT;
CANCER VACCINE;
DRUG DERIVATIVE;
GANCICLOVIR;
VIRUS PROTEIN;
VIRUS VACCINE;
BRAIN;
CANCER;
DISEASE TREATMENT;
NEUROLOGY;
PROTEIN;
VACCINE;
VIRAL DISEASE;
VIRUS;
CANCER CELL;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CARCINOGENESIS;
CLINICAL TRIAL;
CYTOMEGALOVIRUS;
GLIOBLASTOMA;
HUMAN;
IMMUNE RESPONSE;
PRIORITY JOURNAL;
SHORT SURVEY;
SURGEON;
TISSUE SECTION;
VIRUS VIRULENCE;
BRAIN TUMOR;
CYTOMEGALOVIRUS INFECTION;
DNA MICROARRAY;
GENETICS;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
METABOLISM;
NOTE;
PATHOGENICITY;
VIROLOGY;
VIRUS CELL TRANSFORMATION;
CYTOMEGALOVIRUS;
HERPESVIRIDAE;
ANTIVIRAL AGENTS;
BRAIN NEOPLASMS;
CANCER VACCINES;
CELL TRANSFORMATION, VIRAL;
CLINICAL TRIALS AS TOPIC;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
GANCICLOVIR;
GLIOBLASTOMA;
HUMANS;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
VIRAL PROTEINS;
VIRAL VACCINES;
|
EID: 58149215731
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.323.5910.30 Document Type: Short Survey |
Times cited : (40)
|
References (0)
|